Literature DB >> 33314067

Don't forget eclampsia in the efforts to reduce maternal morbidity and mortality.

Wanda K Nicholson1, William Stones2, Gerard H A Visser3, Eytan R Barnea4, Anwar H Nassar5.   

Abstract

Hypertensive disorders are a leading cause of maternal morbidity and mortality worldwide. Despite advances in prevention and clinical management, women in low-resource countries continue to bear the burden of the sequelae of severe pre-eclampsia-eclampsia. Sustainable strategies to improve the care of women with hypertensive disease, to identify those at risk for hypertensive disease, and to reduce the risk of eclampsia will require partnerships between clinicians and health policy makers. Resources are needed to scale up healthcare access and infrastructure, establish evidence-based protocols for care, and ensure an adequate supply of equipment and drugs. Additionally, efforts for a sustained workforce of perinatal clinicians and staff trained in the assessment and management of hypertensive disease are needed. Effective postpartum care and monitoring are essential to prevent morbidity and mortality due to cardiovascular disease. Culturally appropriate strategies are needed to educate women and their families on the symptoms of pre-eclampsia to address delays in seeking care during pregnancy and postpartum. With targeted, sustained efforts and resources, eclampsia and its associated co-morbidities can be preventable.
© 2020 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  cultural norms; eclampsia; health system; maternal health; maternal mortality; severe pre-eclampsia

Mesh:

Year:  2021        PMID: 33314067     DOI: 10.1002/ijgo.13530

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome.

Authors:  Shuangyan Yang; Junfeng Zhang; Dan Chen; Jie Ding; Yanhong Zhang; Lili Song
Journal:  Drugs R D       Date:  2022-09-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.